Coagulation Panel(PT, APTT, Platelates count), in Visit Clinic

PT and PTT are measured on platelet‑poor plasma and evaluate clotting factor pathways, so platelet number or function generally does not affect PT or PTT results. Platelet disorders can cause bleeding even when PT/PTT are normal. Rarely, grossly abnormal samples or extreme thrombocytopenia may interfere with assays, but routine platelet problems don’t change PT/APTT.

Coagulation profile tests include PT and aPTT. PT (prothrombin time) assesses the extrinsic and common clotting pathways (factors II, V, VII, X, fibrinogen) and is used with INR to monitor warfarin. aPTT (activated partial thromboplastin time) evaluates the intrinsic and common pathways (factors XII, XI, IX, VIII, X, V, II, fibrinogen) and monitors heparin therapy. Abnormal values indicate bleeding or clotting disorders.

Prothrombin time (PT) assesses the extrinsic and common coagulation pathways; it helps evaluate bleeding risk and monitor warfarin therapy (reported as INR). Activated partial thromboplastin time (aPTT) assesses the intrinsic and common pathways; it detects deficiencies in factors VIII, IX, XI, XII, monitors unfractionated heparin therapy, and screens for clotting disorders or inhibitors such as lupus anticoagulant.

Activated partial thromboplastin time (aPTT) is a laboratory test that measures how long plasma takes to clot via the intrinsic and common coagulation pathways. It is performed on platelet‑poor plasma with added activators and phospholipid, so it does not directly assess platelet function. A prolonged aPTT suggests factor deficiencies, heparin effect, or circulating inhibitors like lupus anticoagulant and guides diagnosis and anticoagulant monitoring.

A normal platelet count for adults is roughly 150,000–450,000 platelets per microliter (150–450 ×10^9/L) of blood. Laboratories’ reference ranges can vary slightly and children may have different values. Counts below this range suggest thrombocytopenia, increasing bleeding risk; counts above it suggest thrombocytosis, which can raise clotting risk. Abnormal results should be discussed with a clinician.

No. PTT (partial thromboplastin time) is a laboratory test measuring how long the intrinsic and common clotting pathways take to form a clot and evaluates clotting factors and anticoagulant effects. Platelets are cellular fragments that physically form plugs to stop bleeding. Abnormal PTT and abnormal platelet counts indicate different problems and are interpreted together to assess bleeding or clotting disorders.